266 related articles for article (PubMed ID: 7396473)
1. Plaque inhibition assay for drug susceptibility testing of influenza viruses.
Hayden FG; Cote KM; Douglas RG
Antimicrob Agents Chemother; 1980 May; 17(5):865-70. PubMed ID: 7396473
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of activity against influenza viruses by combinations of antiviral agents.
Hayden FG; Douglas RG; Simons R
Antimicrob Agents Chemother; 1980 Oct; 18(4):536-41. PubMed ID: 7447417
[TBL] [Abstract][Full Text] [Related]
3. The relative potencies of anti-influenza compounds.
Tisdale M; Bauer DJ
Ann N Y Acad Sci; 1977 Mar; 284():254-63. PubMed ID: 280137
[TBL] [Abstract][Full Text] [Related]
4. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.
Belshe RB; Burk B; Newman F; Cerruti RL; Sim IS
J Infect Dis; 1989 Mar; 159(3):430-5. PubMed ID: 2915166
[TBL] [Abstract][Full Text] [Related]
5. [Change in the sensitivity of influenza virus, replicating in the presence of rimantadine, to antiviral agents].
Boreko EI; Pavlova NI; Votiakov VI
Vopr Virusol; 1999; 44(3):115-9. PubMed ID: 10392434
[TBL] [Abstract][Full Text] [Related]
6. Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.
Pozo F; Lina B; Andrade HR; Enouf V; Kossyvakis A; Broberg E; Daniels R; Lackenby A; Meijer A;
J Clin Virol; 2013 May; 57(1):5-12. PubMed ID: 23375738
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activities of anti-influenza virus compound T-705.
Furuta Y; Takahashi K; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Watanabe Y; Narita H; Shiraki K
Antimicrob Agents Chemother; 2002 Apr; 46(4):977-81. PubMed ID: 11897578
[TBL] [Abstract][Full Text] [Related]
8. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.
Rahman M; Hoque SA; Islam MA; Rahman SR
Virus Genes; 2017 Jun; 53(3):377-385. PubMed ID: 28401407
[TBL] [Abstract][Full Text] [Related]
10. [Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B].
Reina J
Rev Esp Quimioter; 1999 Mar; 12(1):23-9. PubMed ID: 10209061
[No Abstract] [Full Text] [Related]
11. Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.
Browne MJ; Moss MY; Boyd MR
Antimicrob Agents Chemother; 1983 Mar; 23(3):503-5. PubMed ID: 6847176
[TBL] [Abstract][Full Text] [Related]
12. Anti-influenza virus activity of the compound LY253963.
Hayden FG; Rollins BS; Hay AJ
Antiviral Res; 1990 Jul; 14(1):25-38. PubMed ID: 2080866
[TBL] [Abstract][Full Text] [Related]
13. Amantadine-resistant influenza A virus in Taiwan.
Shih SR; Lee CN; Tsai HR; Chen GW; Tsao KC
J Formos Med Assoc; 2001 Sep; 100(9):608-12. PubMed ID: 11695276
[TBL] [Abstract][Full Text] [Related]
14. Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.
Smee DF; Morrison AC; Barnard DL; Sidwell RW
J Virol Methods; 2002 Oct; 106(1):71-9. PubMed ID: 12367731
[TBL] [Abstract][Full Text] [Related]
15. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
16. Long-term stability of the anti-influenza A compounds--amantadine and rimantadine.
Scholtissek C; Webster RG
Antiviral Res; 1998 Jun; 38(3):213-5. PubMed ID: 9754890
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral activity of metabolites of rimantadine.
Manchand PS; Cerruti RL; Martin JA; Hill CH; Merrett JH; Keech E; Belshe RB; Connell EV; Sim IS
J Med Chem; 1990 Jul; 33(7):1992-5. PubMed ID: 2362279
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of rimantadine resistance in field isolates of influenza A viruses.
Ziegler T; Hemphill ML; Ziegler ML; Perez-Oronoz G; Klimov AI; Hampson AW; Regnery HL; Cox NJ
J Infect Dis; 1999 Oct; 180(4):935-9. PubMed ID: 10479115
[TBL] [Abstract][Full Text] [Related]
19. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
[TBL] [Abstract][Full Text] [Related]
20. Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium.
Burlington DB; Meiklejohn G; Mostow SR
Antimicrob Agents Chemother; 1982 May; 21(5):794-9. PubMed ID: 7103458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
